Rmark Bio,

rMark Bio has designed a blueprint for transforming healthcare data into real-time business intelligence. Our proprietary deep learning platform analyzes global healthcare data in-conjunction with internal clinical research data to optimize partnership and engagement strategies across the life-cycle of a product for healthcare industries including; pharmaceutical, academic institutions, medical device companies, and investment firms. By leveraging rMark Bio’s platform, organizations can significantly reduce time and cost of data analysis while increasing opportunities to align real-time business strategies between their R&D, Product, Commercialization and external teams